美国非酒精性脂肪性肝炎患者的医疗资源利用和护理成本

数据集获取（Figshare）

• 源站标题：Healthcare resource utilization and costs of care in the United States for patients with non-alcoholic steatohepatitis
• DOI：10.6084/m9.figshare.22210171.v1
• 发布日期：2023-03-03
• 文件数：2 个
• 文件总体积：379.59 KB
• 源站页面：https://tandf.figshare.com/articles/dataset/Healthcare_resource_utilization_and_costs_of_care_in_the_United_States_for_patients_with_non-alcoholic_steatohepatitis/22210171

命令行下载

curl -L -o "ijme_a_2184967_sm2082.docx" "https://ndownloader.figshare.com/files/39471841"
curl -L -o "ijme_a_2184967_sm2080.xlsx" "https://ndownloader.figshare.com/files/39471844"

文件清单

• ijme_a_2184967_sm2082.docx（337.21 KB）
• ijme_a_2184967_sm2080.xlsx（42.38 KB）

文件总体积 379.59 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

This retrospective, observational cohort study aimed to determine the burden of comorbidities, hospitalization, and healthcare costs among patients with non-alcoholic steatohepatitis (NASH) in the United States stratified by fibrosis-4 (FIB-4) or body mass index (BMI).
Adults with NASH were identified in the Veradigm Health Insights Electronic Health Record Database and linked Komodo claims data. The index date was the earliest coded NASH diagnosis between 1 January 2016 and 31 December 2020 with valid FIB-4 and ≥6 months of database activity and continuous enrollment pre- and post-index. We excluded patients with viral hepatitis, alcohol-use disorder, or alcoholic liver disease. Patients were stratified by FIB-4: FIB-4 ≤ 0.95, 0.95  4.12) or BMI (BMI 30). Multivariate analysis was used to assess the relationship of FIB-4 with costs and hospitalizations.
Among 6,743 qualifying patients, index FIB-4 was ≤0.95 for 2,345 patents, 0.95–2.67 for 3,289 patients, 2.67–4.12 for 571 patients, and >4.12 for 538 patients (mean age 55.8 years; 62.9% female). Mean age, comorbidity burden, cardiovascular disease risk, and healthcare utilization increased with increasing FIB-4. Mean ± SD annual costs increased from $16,744±$53,810 to $34,667±$67,691 between the lowest and highest FIB-4 cohorts and were higher among patients with BMI 30 ($21,542±$61,490). A one-unit increase in FIB-4 at index was associated with a 3.4% (95%CI: 1.7%–5.2%) increase in mean total annual cost and an 11.6% (95%CI: 8.0%–15.3%) increased likelihood of hospitalization.
A higher FIB-4 was associated with increased healthcare costs and risk of hospitalization in adults with NASH; however, even patients with FIB-4 ≤ 0.95 presented a significant burden.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.22210171.v1（source: https://tandf.figshare.com/articles/dataset/Healthcare_resource_utilization_and_costs_of_care_in_the_United_States_for_patients_with_non-alcoholic_steatohepatitis/22210171）。